Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Medical Condition: Influenza"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Influenza%22&lookfor=%22Humans%22&type=Subject&page=3
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Influenza%22&lookfor=%22Humans%22&type=Subject&page=3
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Influenza%22&lookfor=%22Humans%22&type=Subject&page=3
PubPharm (775)
21
Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months : A Multinational, Comparative Phase III Clinical Trial to Assess the Efficacy (Immunogenicity) and Safety of NBP607-QIV (0.5 mL) (Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine) in Children Aged 6 to 35 Months
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
22
Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age : Efficacy, Immunogenicity, and Safety of High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
23
Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine : Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine in Children Aged 6 Months to 17 Years
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
24
Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam : Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
25
Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects : A Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of H10N8 Antigen mRNA in Healthy Adult Subjects
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
26
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India : Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
27
Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children : Prevalence, Genetic Risk Factor and the Use of Intradermally-administered Inactivated Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
28
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years. : Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Vaccine in Children Aged 6 to 17 Years (Inclusive)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
29
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US : Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Participants Aged 65 Years and Older
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
30
Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok : Evaluation of the Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok® Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine in Healthy Adults Aged 18 to 49 Years
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[78]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Influenza
Medienart
775
Aufsätze
775
E-Artikel
775
E-Ressourcen
Zeitschriftentitel
775
ClinicalTrials.gov
Thema
775
610
775
Influenza, Human
Medical Condition: Influenza
714
Study Type: Interventional
673
Recruitment Status: Completed
174
Phase: Phase 3
158
Phase: Phase 2
139
Phase: Phase 4
115
Phase: Phase 1
60
Study Type: Observational
49
Phase: Phase 1/Phase 2
45
Recruitment Status: Unknown status
30
Influenza in Birds
25
Recruitment Status: Terminated
19
Recruitment Status: Withdrawn
13
Phase: Phase 2/Phase 3
5
Recruitment Status: Not yet recruiting
4
Emergencies
3
Recruitment Status: Suspended
2
Infection
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
95
2020-
636
2010-2019
44
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
775
Englisch
Haven't found what you're looking for?
Wird geladen...